Dynavax Technologies Corporation (NASDAQ:DVAX) Archives - BioPharmaJournal

Home Tags Dynavax Technologies Corporation (NASDAQ:DVAX)

Dynavax Technologies Corporation (NASDAQ:DVAX) Reports Record HEPLISAV-B® Vaccine Net Revenue Of...

Matt Wade - November 13, 2020 0

Dynavax Technologies’(NASDAQ:DVAX) Appoints Peter Paradiso To Board And Its CFO To...

Gavins Felicity - October 1, 2020 0

The Bill & Melinda Gates Foundation Grants Dynavax Technologies Corporation (NASDAQ:DVAX)...

Kate Hudson - August 19, 2020 0

TriSalus Life Sciences Enters into an Asset Purchase Agreement under Which...

Gavins Felicity - August 13, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX)’s Collaboration with Mount Sinai to Develop a...

Kate Hudson - July 23, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Partners with Medicago to Investigate and Evaluate...

Matt Wade - July 16, 2020 0

Clover Biopharmaceuticals Commences Study On COVID-19 Vaccine Using Dynavax Technologies’ (NASDAQ:DVAX)...

Matt Wade - June 29, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Completes Enrolment IN Study Evaluating Hepatitis B...

Gavins Felicity - June 23, 2020 0

.td-post-views{ display: none !important; }